Immune responses and protection in children in developing countries induced by oral vaccines

Vaccine

Volumn 31, Issue 3, 2013, Pages 452-460

  Qadri, Firdausi ^a   Bhuiyan, Taufiqur Rahman ^a   Sack, David A ^b   Svennerholm, Ann Mari ^c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Hypo responsiveness; Immunity; Malnutrition; Mucosal immunology

Indexed keywords

BCG VACCINE; CHOLERA VACCINE; ESCHERICHIA COLI VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; RETINOL; ROTAVIRUS VACCINE; SHIGELLA VACCINE; TETANUS TOXOID; TRACE ELEMENT; TYPHOID VACCINE; VACCINE; VITAMIN D; ZINC;

BREAST FEEDING; CHILD NUTRITION; DEVELOPING COUNTRY; DIARRHEA; DRUG EFFICACY; ENTEROPATHY; ENTEROTOXIGENIC ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MALNUTRITION; MEASLES; METABOLOMICS; METAGENOMICS; MUCOSAL IMMUNITY; NONHUMAN; PARASITOSIS; PNEUMONIA; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; ROTAVIRUS INFECTION; SHIGELLOSIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TH17 CELL; TREATMENT RESPONSE; TUBERCULOSIS; TYPHOID FEVER; VITAMIN SUPPLEMENTATION; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; HUMANS; IMMUNITY, MUCOSAL; INFANT; INFANT, NEWBORN; INTESTINAL DISEASES; MALNUTRITION; VACCINES;

EID: 84871648954     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.012     Document Type: Review

References (126)

1. Pasetti M.F., Simon J.K., Sztein M.B., Levine M.M. Immunology of gut mucosal vaccines. Immunol Rev 2011, 239(January (1)):125-148.
2. Sack D.A.Q.F, Svennerholm A.-M. Determinants of responses to oral vaccines in developing countries. Ann Nestle' (Engl) 2008, 66:71-79.
3. Young child survival and development 2009, United Nations Children's Fund.
4. Black R.E., Morris S.S., Bryce J. Where and why are 10 million children dying every year?. Lancet 2003, 361(June (9376)):2226-2234.
5. Black R.E., Allen L.H., Bhutta Z.A., Caulfield L.E., de Onis M., Ezzati M., et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008, 371(January (9608)):243-260.
6. Tracking progress on child and maternal nutrition: a survival and development priority 2009, United Nations Children's Fund.
7. Bhutta Z.A., Ahmed T., Black R.E., Cousens S., Dewey K., Giugliani E., et al. What works? Interventions for maternal and child undernutrition and survival. Lancet 2008, 371(February (9610)):417-440.
8. Richie E.E., Punjabi N.H., Sidharta Y.Y., Peetosutan K.K., Sukandar M.M., Wasserman S.S., et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta Indonesia, a cholera-endemic area. Vaccine 2000, 18(May (22)):2399-2410.
9. Lagos R., Fasano A., Wasserman S.S., Prado V., San Martin O., Abrego P., et al. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J Infect Dis 1999, 180(November (5)):1709-1712.
10. Chowdhury M.I., Sheikh A., Qadri F. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009. Expert Rev Vaccines 2009, 8(December (12)):1643-1652.
11. Holmgren J.K.J. Oral cholera vaccines. New generation vaccines 2010, 506-515. Informa Health Care, New York, USA. 4th ed. M.M. Levine (Ed.).
12. Sack D.A., Clemens J.D., Huda S., Harris J.R., Khan M.R., Chakraborty J., et al. Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh. J Infect Dis 1991, 164(August (2)):407-411.
13. Sur D., Kanungo S., Sah B., Manna B., Ali M., Paisley A.M., et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Neglect Trop Dis 2011, 5(October (10)):e1289.
14. Saha A., Chowdhury M.I., Khanam F., Bhuiyan M.S., Chowdhury F., Khan A.I., et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine 2011, 29(October (46)):8285-8292.
15. Hallander H.O., Paniagua M., Espinoza F., Askelof P., Corrales E., Ringman M., et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 2002, 21(November (1-2)):138-145.
16. Svennerholm A.M. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res 2011, 133(February):188-196.
17. Sack D.A., Shimko J., Torres O., Bourgeois A.L., Francia D.S., Gustafsson B., et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhoea of travellers to Guatemala and Mexico. Vaccine 2007, 25(May (22)):4392-4400.
18. Bourgeois A.L., Halpern J., Grahek S., Golub S., Gustafsson B., Svennerholm A.-M., et al. Vaccination of travellers to Guatemala (GU) and Mexico (MX) with an oral killed vaccine (OKV) for enterotoxigenic E. coli (ETEC): impact of vaccine " take" on risk of ETEC disease and infection with enteric pathogens. 4th international conference on vaccines for enteric diseases (VED 2007) 2007.
19. Walker R.I., Steele D., Aguado T. Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease. Vaccine 2007, 25(March (14)):2545-2566.
20. Norton E.B., Lawson L.B., Freytag L.C., Clements J.D. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin Vaccine Immunol: CVI 2011, 18(April (4)):546-551.
21. Svennerholm A.M., Lundgren A. Recent progress toward an enterotoxigenic Escherichia coli vaccine. Expert Rev Vaccines 2011, 11(April (4)):495-507.
22. Harro C., Sack D., Bourgeois A.L., Walker R., DeNearing B., Feller A., et al. A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol: CVI 2011, 18(December (12)):2118-2127.
23. Levine M.M., Kotloff K.L., Barry E.M., Pasetti M.F., Sztein M.B. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007, 5(July (7)):540-553.
24. Barzu S., Arondel J., Guillot S., Sansonetti P.J., Phalipon A. Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602. Infect Immun 1998, 66(January (1)):77-82.
25. Katz D.E., Coster T.S., Wolf M.K., Trespalacios F.C., Cohen D., Robins G., et al. Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infect Immun 2004, 72(February (2)):923-930.
26. Rahman K.M., Arifeen S.E., Zaman K., Rahman M., Raqib R., Yunus M., et al. Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. Vaccine 2011, 29(February (6)):1347-1354.
27. Phalipon A., Mulard L.A., Sansonetti P.J. Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?. Microbes Infect 2008, 10(July (9)):1057-1062.
28. Kawai K., O'Brien M.A., Goveia M.G., Mast T.C., El Khoury A.C. Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine 2012, 30(February (7)):1244-1254.
29. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(January (1)):11-22.
30. Parashar U.D., Gibson C.J., Bresse J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12(February (2)):304-306.
31. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(August (9741)):606-614.
32. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(January (1)):23-33.
33. Holmgren J., Svennerholm A.M. Vaccines against mucosal infections. Curr Opin Immunol 2011, 24(June (3)):343-353.
34. Wang Y., Azevedo M., Saif L.J., Gentsch J.R., Glass R.I., Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine 2010, 28(July (33)):5432-5436.
35. Nookala S., Srinivasan S., Kaliraj P., Narayanan R.B., Nutman T.B. Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun 2004, 72(May (5)):2598-2604.
36. Sabin E.A., Araujo M.I., Carvalho E.M., Pearce E.J. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 1996, 173(January (1)):269-272.
37. van Riet E., Hartgers F.C., Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007, 212(6):475-490.
38. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 82(May (5)):346-353.
39. Fraser A., Paul M., Goldberg E., Acosta C.J., Leibovici L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 2007, 25(November (45)):7848-7857.
40. Gilman R.H., Hornick R.B., Woodard W.E., DuPont H.L., Snyder M.J., Levine M.M., et al. Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis 1977, 136(December (6)):717-723.
41. Sinha A., Sazawal S., Kumar R., Sood S., Reddaiah V.P., Singh B., et al. Typhoid fever in children aged less than 5 years. Lancet 1999, 354(August (9180)):734-737.
42. Lundgren A., Kaim J., Jertborn M. Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods. Vaccine 2009, 27(July (33)):4529-4536.
43. Thiem V.D., Lin F.Y., Canh do G., Son N.H., Anh D.D., Mao N.D., et al. The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines. Clin Vaccine Immunol: CVI 2011, 18(May (5)):730-735.
44. Ogra P.L., Okayasu H., Czerkinsky C., Sutter R.W. Mucosal immunity to poliovirus. Expert Rev Vaccines 2011, 10(October (10)):1389-1392.
45. Grassly N.C., Fraser C., Wenger J., Deshpande J.M., Sutter R.W., Heymann D.L., et al. New strategies for the elimination of polio from India. Science 2006, 314(November (5802)):1150-1153.
46. Okayasu H., Sutter R.W., Czerkinsky C., Ogra P.L. Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission. Vaccine 2011, 29(October (46)):8205-8214.
47. Gnanashanmugam D., Troy S.B., Musingwini G., Huang C., Halpern M.S., Stranix-Chibanda L., et al. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children. Pediatr Infect Dis J 2012, 31(February (2)):176-180.
48. Sutter R.W., John T.J., Jain H., Agarkhedkar S., Ramanan P.V., Verma H., et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet 2011, 376(November (9753)):1682-1688.
49. Lasch E.E., Abed Y., Marcus O., Gerichter C.B., Melnick J.L. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country - five years after. Dev Biol Stand 1986, 65:137-143.
50. Licciardi P.V., Balloch A., Russell F.M., Burton R.L., Lin J., Nahm M.H., et al. Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses. J Allergy Clin Immunol 2011, 129(March (3)):794-800. e2.
51. Mittal S.K., Aggarwal V., Rastogi A., Saini N., Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis?. Indian J Pediatr 1996, 63(September-October (5)):659-664.
52. Edwards L.B., Acquaviva F.A., Livesay V.T. Identification of tuberculous infected. Dual tests and density of reaction. Am Rev Respir Dis 1973, 108(December (6)):1334-1339.
53. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Thollot F., et al. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine 2011, 28(July (32)):5272-5279.
54. Tregnaghi M.W., Abate H.J., Valencia A., Lopez P., Da Silveira T.R., Rivera L., et al. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatr Infect Dis J 2011, 30(June (6)):e103-e108.
55. Steele A.D., Reynders J., Scholtz F., Bos P., de Beer M.C., Tumbo J., et al. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants. J Infect Dis 2011, 202(September (Suppl.)):S93-S100.
56. Zaman K., Sack D.A., Yunus M., Arifeen S.E., Podder G., Azim T., et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009, 27(February (9)):1333-1339.
57. WHO Health Statistics 2012.
58. Salomon J.B., Gordon J.E., Scrimshaw N.S. Studies of diarrheal disease in Central America X. Associated chickenpox, diarrhea and kwashiorkor in a highland Guatemalan village. Am J Trop Med Hyg 1966, 15(November (6)):997-1002.
59. Scrimshaw N.S., Salomon J.B., Bruch H.A., Gordon J.E. Studies of diarrheal disease in Central America 8. Measles, diarrhea, and nutritional deficiency in rural Guatemala. Am J Trop Med Hyg 1966, 15(July (4)):625-631.
60. Hong R., Banta J.E., Betancourt J.A. Relationship between household wealth inequality and chronic childhood under-nutrition in Bangladesh. Int J Equity Health 2006, 5:15.
61. Cassani B., Villablanca E.J., De Calisto J., Wang S., Mora J.R. Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol Aspects Med 2011, 33(February (1)):63-76.
62. Green H.N., Mellanby E. Vitamin A as an anti-infective agent. Br Med J 1928, 2(October (3537)):691-696.
63. Sommer A. Uses and misuses of vitamin A. Curr Issues Public Health 1996, 2(August (4)):161-164.
64. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2011, 375(June (9730)):1969-1987.
65. Cha H.R., Chang S.Y., Chang J.H., Kim J.O., Yang J.Y., Kim C.H., et al. Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic acid. J Immunol 2011, 184(June (12)):6799-6806.
66. Newton S., Owusu-Agyei S., Ampofo W., Zandoh C., Adjuik M., Adjei G., et al. Vitamin A supplementation enhances infants' immune responses to hepatitis B vaccine but does not affect responses to Haemophilus influenzae type b vaccine. J Nutr 2007, 137(May (5)):1272-1277.
67. Scott C.L., Aumeunier A.M., Mowat A.M. Intestinal CD103+ dendritic cells: master regulators of tolerance?. Trends Immunol 2011, 32(September (9)):412-419.
68. Semmrich M., Plantinga M., Svensson-Frej M., Uronen-Hansson H., Gustafsson T., Mowat A.M., et al. Directed antigen targeting in vivo identifies a role for CD103(+) dendritic cells in both tolerogenic and immunogenic T-cell responses. Mucosal Immunol 2011, 5(March (2)):150-160.
69. Lima A.A., Soares A.M., Lima N.L., Mota R.M., Maciel B.L., Kvalsund M.P., et al. Effects of vitamin A supplementation on intestinal barrier function, growth, total parasitic, and specific Giardia spp infections in Brazilian children: a prospective randomized, double-blind, placebo-controlled trial. J Pediatr Gastroenterol Nutr 2011, 50(March (3)):309-315.
70. Surman S.L., Rudraraju R., Sealy R., Jones B., Hurwitz J.L. Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract. Viral Immunol 2011, (July).
71. Albert M.J., Qadri F., Wahed M.A., Ahmed T., Rahman A.S., Ahmed F., et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis 2003, 187(March (6)):909-913.
72. Benn C.S., Fisker A.B., Napirna B.M., Roth A., Diness B.R., Lausch K.R., et al. Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ 2011, 340:c1101.
73. Semba R.D., Munasir Z., Beeler J., Akib A., Muhilal, Audet S., et al. Reduced seroconversion to measles in infants given vitamin A with measles vaccination. Lancet 1995, 345(May (8961)):1330-1332.
74. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006, 134(December (6)):1129-1140.
75. Zitt E., Sprenger-Mahr H., Knoll F., Neyer U., Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine 2011, 30(January (5)):931-935.
76. Brooks W.A., Yunus M., Santosham M., Wahed M.A., Nahar K., Yeasmin S., et al. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet 2004, 363(May (9422)):1683-1688.
77. Ahmed T., Svennerholm A.M., Al Tarique A., Sultana G.N., Qadri F. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine 2009, 27(February (9)):1433-1439.
78. Qadri F., Ahmed T., Wahed M.A., Ahmed F., Bhuiyan N.A., Rahman A.S., et al. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed B subunit-whole cell, oral cholera vaccine. Vaccine 2004, 22(January (3-4)):416-421.
79. Osendarp S.J., Prabhakar H., Fuchs G.J., van Raaij J.M., Mahmud H., Tofail F., et al. Immunization with the heptavalent pneumococcal conjugate vaccine in Bangladeshi infants and effects of zinc supplementation. Vaccine 2007, 25(April (17)):3347-3354.
80. Wintergerst E.S., Maggini S., Hornig D.H. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 2007, 51(4):301-323.
81. Costa L.B., Noronha F.J., Roche J.K., Sevilleja J.E., Warren C.A., Oria R., et al. Novel in vitro and in vivo models and potential new therapeutics to break the vicious cycle of Cryptosporidium infection and malnutrition. J Infect Dis 2011, 205(May (9)):1464-1471.
82. Victora C.G., de Onis M., Hallal P.C., Blossner M., Shrimpton R. Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics 2011, 125(March (3)):e473-e480.
83. Sternberg R.J. Intelligence and lifelong learning. What's new and how can we use it?. Am Psychol 1997, 52(October (10)):1134-1139.
84. Grantham-McGregor S.M., Walker S.P., Chang S.M., Powell C.A. Effects of early childhood supplementation with and without stimulation on later development in stunted Jamaican children. Am J Clin Nutr 1997, 66(August (2)):247-253.
85. Dewey K.G., Adu-Afarwuah S. Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutr 2008, 4(April (Suppl. 1)):24-85.
86. Bauchner H., Leventhal J.M., Shapiro E.D. Studies of breast-feeding and infections. How good is the evidence?. JAMA 1986, 256(August (7)):887-892.
87. Gordon J.E., Chitkara I.D., Wyon J.B. Weanling diarrhea. Am J Med Sci 1963, 245(March):345-377.
88. Waterlow J.C., Thomson A.M. Observations on the adequacy of breast-feeding. Lancet 1979, 2(August (8136)):238-242.
89. Ahmed F., Clemens J.D., Rao M.R., Sack D.A., Khan M.R., Haque E. Community-based evaluation of the effect of breast-feeding on the risk of microbiologically confirmed or clinically presumptive shigellosis in Bangladeshi children. Pediatrics 1992, 90(September (3)):406-411.
90. Clemens J.D., Rao M.R., Chakraborty J., Yunus M., Ali M., Kay B., et al. Breastfeeding and the risk of life-threatening enterotoxigenic Escherichia coli diarrhea in Bangladeshi infants and children. Pediatrics 1997, 100(December (6)):E2.
91. Clemens J.D., Sack D.A., Harris J.R., Khan M.R., Chakraborty J., Chowdhury S., et al. Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am J Epidemiol 1990, 131(March (3)):400-411.
92. Cravioto A., Reyes R.E., Ortega R., Fernandez G., Hernandez R., Lopez D. Prospective study of diarrhoeal disease in a cohort of rural Mexican children: incidence and isolated pathogens during the first two years of life. Epidemiol Infect 1988, 101(August (1)):123-134.
93. Cravioto A., Reyes R.E., Trujillo F., Uribe F., Navarro A., De La Roca J.M., et al. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am J Epidemiol 1990, 131(May (5)):886-904.
94. Rennels M.B. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 1996, 174(September (Suppl. 1)):S107-S111.
95. VanDerslice J., Popkin B., Briscoe J. Drinking-water quality, sanitation, and breast-feeding: their interactive effects on infant health. Bull World Health Organ 1994, 72(4):589-601.
96. Glass R.I., Svennerholm A.M., Stoll B.J., Khan M.R., Hossain K.M., Huq M.I., et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 1983, 308(June (23)):1389-1392.
97. Holmgren J., Svennerholm A.M., Lindblad M. Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination). Infect Immun 1983, 39(January (1)):147-154.
98. Morrow A.L., Ruiz-Palacios G.M., Jiang X., Newburg D.S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 2005, 135(May (5)):1304-1307.
99. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21(July (24)):3406-3412.
100. Clemens J.D., Jertborn M., Sack D., Stanton B., Holmgren J., Khan M.R., et al. Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine. J Infect Dis 1986, 154(July (1)):175-178.
101. Mondal D., Minak J., Alam M., Liu Y., Dai J., Korpe P., et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis 2011, 54(January (2)):185-192.
102. Petri W.A., Miller M., Binder H.J., Levine M.M., Dillingham R., Guerrant R.L. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest 2008, 118(April (4)):1277-1290.
103. Oria R.B., Patrick P.D., Zhang H., Lorntz B., de Castro Costa C.M., Brito G.A., et al. APOE4 protects the cognitive development in children with heavy diarrhea burdens in Northeast Brazil. Pediatr Res 2005, 57(February (2)):310-316.
104. Azevedo O.G.R., Roche J.K., Lima A.A.M., Vitek M., Oria R.B., Guerrant R.L. APOE4 targeted replacement and APOE knockout weaning mice have distinct adaptations following Cryptosporidium parvum infection and malnutrition 2012, International Research in Infectious Disease, Bethesda, MD.
105. Ajjampur S.S., Koshy B., Venkataramani M., Sarkar R., Joseph A.A., Jacob K.S., et al. Effect of cryptosporidial and giardial diarrhoea on social maturity, intelligence and physical growth in children in a semi-urban slum in south India. Ann Trop Paediatr 2011, 31(3):205-212.
106. Al-Mekhlafi M.S., Azlin M., Nor Aini U., Shaik A., Sa'iah A., Fatmah M.S., et al. Giardiasis as a predictor of childhood malnutrition in Orang Asli children in Malaysia. Trans R Soc Trop Med Hyg 2005, 99(September (9)):686-691.
107. Fraser D., Bilenko N., Deckelbaum R.J., Dagan R., El-On J., Naggan L. Giardia lamblia carriage in Israeli Bedouin infants: risk factors and consequences. Clin Infect Dis 2000, 30(March (3)):419-424.
108. Nematian J., Gholamrezanezhad A., Nematian E. Giardiasis and other intestinal parasitic infections in relation to anthropometric indicators of malnutrition: a large, population-based survey of schoolchildren in Tehran. Ann Trop Med Parasitol 2008, 102(April (3)):209-214.
109. Berkman D.S., Lescano A.G., Gilman R.H., Lopez S.L., Black M.M. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet 2002, 359(February (9306)):564-571.
110. Gupta M.C., Urrutia J.J. Effect of periodic antiascaris and antigiardia treatment on nutritional status of preschool children. Am J Clin Nutr 1982, 36(July (1)):79-86.
111. Jimenez J.C., Rodriguez N., Di Prisco M.C., Lynch N.R., Costa V. Haemoglobin concentrations and infection by Giardia intestinalis in children: effect of treatment with secnidazole. Ann Trop Med Parasitol 1999, 93(December (8)):823-827.
112. Monajemzadeh S.M., Monajemzadeh M. Comparison of iron and hematological indices in Giardia lamblia infection before and after treatment in 102 children in Ahwaz, Iran. Med Sci Monit 2008, 14(January (1)):CR19-CR23.
113. Quihui-Cota L., Astiazaran-Garcia H., Valencia M.E., Morales-Figueroa G.G., Lopez-Mata M.A., Vazquez Ortiz F. Impact of Giardia intestinalis on vitamin a status in schoolchildren from northwest Mexico. Int J Vitam Nutr Res 2008, 78(March (2)):51-56.
114. Guerrant R.L., Hughes J.M., Lima N.L., Crane J. Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis 1990, 12(January-February (Suppl. 1)):S41-S50.
115. Opintan J.A., Newman M.J., Ayeh-Kumi P.F., Affrim R., Gepi-Attee R., Sevilleja J.E., et al. Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg 2011, 83(October (4)):936-943.
116. Vollmer J., Krieg A.M. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev 2009, 61(March (3)):195-204.
117. Cooper P.J., Chico M., Sandoval C., Espinel I., Guevara A., Levine M.M., et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun 2001, 69(March (3)):1574-1580.
118. Humphrey J.H. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009, 374(September (9694)):1032-1035.
119. Veitch A.M., Kelly P., Zulu I.S., Segal I., Farthing M.J. Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol 2001, 13(October (10)):1175-1181.
120. Campbell D.I., Murch S.H., Elia M., Sullivan P.B., Sanyang M.S., Jobarteh B., et al. Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr Res 2003, 54(September (3)):306-311.
121. Lagos R., San Martin O., Wasserman S.S., Prado V., Losonsky G.A., Bustamante C., et al. Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers. Pediatr Infect Dis J 1999, 18(July (7)):624-630.
122. Myaux J.A., Unicomb L., Besser R.E., Modlin J.F., Uzma A., Islam A.M., et al. Effect of diarrhea on the humoral response to oral polio vaccination. Pediatr Infect Dis J 1996, 15(March (3)):204-209.
123. Ahmed T., Mahfuz M., Ireen S., Ahmed A.M., Rahman S., Islam M.M., et al. Nutrition of children and women in Bangladesh: trends and directions for the future. J Health Popul Nutr 2011, 30(March (1)):1-11.
124. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444(December (7122)):1022-1023.
125. Gupta S.S., Mohammed M.H., Ghosh T.S., Kanungo S., Nair G.B., Mande S.S. Metagenome of the gut of a malnourished child. Gut Pathog 2011, 3:7.
126. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474(June (7351)):327-336.